Skip to main content
College of Veterinary Medicine

Anthrax may be the next tool in the fight against bladder cancer

November 13, 2019

Anthrax may soon help more people win the fight against bladder cancer, which the U.S. Centers for Disease Control and Prevention says strikes about 72,000 Americans each year and kills about 16,000, and is one of the most expensive cancers to treat.

The image features three scientific visuals, including an endoscopic view, an ultrasound image, and a microscopy image of a cellular structure.
Pet dogs suffering bladder cancer, for which all other approaches failed, were treated with a Purdue University experimental approach. A: Bladder cystoscopic biopsy being performed in patient dog to investigate tumor characteristics. B: Ultrasound image obtained to record tumor mass dimensions. Sagittal view of the bladder. Arrows point to mass in the neck of the bladder. C: Presence of Epidermal Growth Factor (EGF) Receptor on bladder cancer cells was revealed by binding and uptake of fluorescently labeled EGF (red). Nucleus (blue) and actin cytoskeleton (green) are also shown. (Image Provided)

The current treatments for bladder cancer are invasive for patients – who often must sit for hours at a time with a bladder full of an agent designed to kill cancer cells and tumors. Bladder cancer also is one of the most recurring for people diagnosed with the disease.

Now, researchers at Purdue University have come up with a way to combine the anthrax toxin with a growth factor to kill bladder cancer cells and tumors. The research is published in the Oct. 4 edition of the International Journal of Cancer.

R. Claudio Aguilar and his group worked with the Purdue teams led by Timothy Ratliff, a distinguished professor of comparative pathobiology and the Robert Wallace Miller Director of Purdue University Center for Cancer Research; and Deborah Knapp, the Dolores L. McCall Professor of Comparative Oncology and director of the Purdue Comparative Oncology Program, to test their solution in dogs with bladder cancer who had run out of other treatment options. They found this new agent decreased the tumor size without causing any other side effects in the animals.

Read the full story at Anthrax may be the next tool in the fight against bladder cancer

Recent Stories

Purdue Veterinary Medicine Welcomes New Clinical Residents and Specialty Intern

A new class of clinical residents arrived this summer at the Purdue University College of Veterinary Medicine to begin their specialty training. On July 16, 2026, the Department of Veterinary Clinical Sciences (VCS) held a welcome breakfast to introduce the new VCS residents to faculty and staff. The breakfast provided the opportunity for the new residents and a new specialty intern in neurology to meet current VCS residents, as well as the faculty and staff they will be working closely with during their time at Purdue.

American Board of Veterinary Toxicology Honors Purdue Professor and ADDL Senior Veterinary Toxicologist Steve Hooser

Dr. Steve Hooser, DVM, PhD, DABVT, professor of veterinary toxicology at the Purdue University College of Veterinary Medicine and senior veterinary toxicologist for the Indiana Animal Disease Diagnostic Laboratory (ADDL), has received the American Board of Veterinary Toxicology's (ABVT) 2026 Service Award.  Given in recognition of a career that has shaped the field of veterinary toxicology for more than four decades, the award was announced July 13 at the ABVT Annual Business meeting held in Anaheim, California, in conjunction with the AVMA Convention 2026.

New Class of Veterinary Hospital Interns and Pharmacy Resident Welcomed to PVM

A total of 13 new interns and a new veterinary pharmacy resident began their advanced training in the Purdue University Veterinary Hospital this summer. The group of interns includes nine veterinarians who are completing a small animal rotating internship and four who are doing a large animal rotating internship. In addition, a pharmacy school graduate began the one year Wasson Veterinary Pharmacy Residency program, which is jointly offered by the Purdue Colleges of Veterinary Medicine and Pharmacy.

“Paws Up” for Lilia Beal-Preston and Mikey Galvin – brought to you by the PVM Wellness Committee

This week, we’re proud to recognize DVM students Lilia Beal-Preston and Mikey Galvin, who received a Paws Up recognition from a client after caring for the client's dog at the Purdue University Veterinary Hospital.

“Paws Up” for Jennifer Danaher – brought to you by the PVM Wellness Committee

Today we are congratulating Jennifer Danaher, who is a department secretary for Veterinary Clinical Sciences, for being recognized as a helpful colleague in our college.

Boo the Miracle Dog: A Story of Bravery, Breakthroughs, and a Bond That Inspires

Our series of articles about animals and their owners who've found help and healing at the Purdue University Veterinary Hospital continues with the story of "miracle dog" Boo Davis. At 13 years old, Boo Davis is living proof of the power of persistence, expert veterinary care, and the unshakable love between a pet and her person. Affectionately known as Lisa’s “miracle dog,” Boo’s journey is one that not only has extended her life, but also has helped shape the future of cancer treatment for other pets, too.

Placating Pets to Help them COPE this Fourth of July

Despite the excellent tips experts provide each year for pet safety and welfare on the 4th of July, many pet families still run into trouble and lose their pets. What are we missing and how can we even better protect our animal companions? That question is answered in an article by Dr. Candace Croney, director of the Center for Animal Welfare Science.